Imperia Feverfew
Natural health product licensed in Canada
- Other names
- Imperia Migraine Away
- Licence holder
- Imperia Brand Strategies & Solutions Ltd.
- NPN or DIN-HM
- 80044912
- Status
- Active licence
- Licence date
- 24 September 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Croscarmellose de sodium, Stéarate de magnésium, Cellulose microcristalline, Phosphate dicalcique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 day |
Uses authorised in Canada
(Used in Herbal Medicine to) help(s) reduce the severity and/or frequency of migraine headaches and associated symptoms such as nausea and vomiting, when taken as a prophylactic. (Used in Herbal Medicine to) help(s) prevent migraine headaches.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant. Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
- Effets indésirables connus
Some people may experience sore mouth, mouth ulcers and/or gastrointestinal discomfort. Hypersensitivity, such as an allergy, has been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you are breastfeeding. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner if symptoms persist.
Source
Official Health Canada record, licence 80044912
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.